Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

The Role of Health, Learning and Leadership Institutions in Schistosomiasis Research Uptake in Ingwavuma Area, uMkhanyakude District, KwaZulu-Natal, South Africa.

Mindu T, Chimbari MJ, Msesengwa R. Research Square. 2021;
Download PDF
Publication

Determinants of snakebite mortality in Asia: A systematic review.

Ibadullah W, Azmi M, Abas M, et al. Annals of medicine and surgery (2012). 2021;
Download PDF
Publication

Lessons from the Field: Integrated survey methodologies for neglected tropical diseases.

Harding-Esch EM, Brady M, Angeles C, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2021; 115 (2) : 124-126.
Download PDF
Publication

Quality and composition of Albendazole, Mebendazole and Praziquantel available in Burkina Faso, Côte d'Ivoire, Ghana and Tanzania.

Seitzer M, Klapper S, Mazigo H, et al. PLoS neglected tropical diseases. 2021; 15 (1) : e0009038.
Download PDF
Publication

Individual adherence to mass drug administration in neglected tropical disease control: A probability model conditional on past behaviour.

Hardwick RJ, Truscott J, Oswald W, et al. PLoS neglected tropical diseases. 2021; 15 (1) : e0009112.
Download PDF
Publication

Forecasting the effectiveness of the DeWorm3 trial in interrupting the transmission of soil-transmitted helminths in three study sites in Benin, India and Malawi.

Truscott J, Hardwick RJ, Werkman M, et al. Parasites & vectors. 2021; 14 (1) : 67.
Download PDF
Publication

Assessment of surveillance core and support functions regarding neglected tropical diseases in Kenya.

Ng'etich A, Voyi K, Mutero C. BMC public health. 2021; 21 (1) : 142.
Download PDF
Publication

Overview of snakebite in Brazil: Possible drivers and a tool for risk mapping.

Schneider M, Min K, Hamrick P, et al. PLoS neglected tropical diseases. 2021; 15 (1) : e0009044.
Download PDF
Publication

Delivering health interventions to women, children, and adolescents in conflict settings: what have we learned from ten country case studies?

Singh NS, Ataullahjan A, Ndiaye K, et al. Elsevier BV. The Lancet. 2021;
Publication

Delivering health and nutrition interventions for women and children in different conflict contexts: a framework for decision making on what, when, and how

Gaffey MF, Waldman RJ, Blanchet K, et al. Elsevier BV. The Lancet. 2021;

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 464
  • Page 465
  • Page 466
  • Page 467
  • Current page 468
  • Page 469
  • Page 470
  • Page 471
  • Page 472
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD